In a research report released Friday, Cantor analyst Elemer Piros reiterated a Sell rating on shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT), with a price …
Roth Capital’s healthcare analyst Elemer Piros weighed in today with his views on Conatus Pharmaceuticals Inc (NASDAQ:CNAT), after the company announced positive data on the early …
OHR Pharmaceutical Inc (NASDAQ:OHRP) shares have taken off, adding 44.05% to trade at $3.
Roth Capital analyst Elemer Piros offered commentary on Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) following the licensing of a program to treat a wide variety of rare blood …
Roth Capital analyst Elemer Piros initiated coverage on Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI) after looking at the company’s world-class gene and protein therapeutics portfolio for …
The first quarter of 2015 has come to a close and companies are still releasing earnings reports. Let’s look back and see which …
OHR Pharmaceutical Inc (NASDAQ:OHRP) shares plunged nearly 70% today after the company announced topline results from its exploratory phase II IMPACT study testing OHR-102 in combination with Lucentis …
